Ex Parte Dorsel et al - Page 4

                Appeal  2007-1132                                                                            
                Application 10/036,999                                                                       
                      We reverse the rejection of claims 2-5, 7-11, and 18-20.  We affirm                    
                the rejection of claim 1.  However, because our reasoning differs from that                  
                of the Examiner we designate our affirmance as a new ground of rejection.                    

                                               DISCUSSION                                                    
                      The claimed invention relates to methods of scanning an array, e.g., a                 
                polynucleotide array (Specification 1; claims).  Polynucleotide “arrays                      
                include features (sometimes referenced as spots or regions) of usually                       
                different sequence polynucleotides arranged in a predetermined                               
                configuration on a substrate” (Specification 1).  For clarity, we direct                     
                attention to Appellants’ Figures 1 and 2, which illustrate a predetermined                   
                configuration of features (16) on the face (12) of the substrate (10)                        
                (Specification 8; Figures 1 and 2).  According to Appellants’ Specification                  
                the features “are disposed in a pattern which defines the array”                             
                (Specification 8).                                                                           
                      Therefore, when exposed to a sample the array will exhibit a binding                   
                pattern.  The array can then                                                                 
                      be interrogated by observing this binding pattern by, for                              
                      example, labeling all polynucleotide targets . . . in a sample                         
                      with a suitable label (such as a fluorescent compound),                                
                      scanning an interrogating light across the array and accurately                        
                      observing the fluorescent signal from the different features of                        
                      the array.  Assuming that the different sequence                                       
                      polynucleotides were correctly deposited in accordance with the                        
                      predetermined configuration, then the observed binding pattern                         
                      will be indicative of the presence and/or concentration of one or                      
                      more polynucleotide components of the sample.                                          
                (Specification 2.)                                                                           


                                                     4                                                       

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next

Last modified: September 9, 2013